APP and Alzheimer disease: Since site-specific phosphorylation on serine and threonine residues are known to influence APP’s fate [81–83], we presumed that TMG intranasal treatment could exert beneficial effects on APP cleavage on Ts2Cje, as reported for AD murine models [84, 85].